3505 results for «2054»

Filter By

3505 results

Managing TAVI complications

20 May 2025 – From EuroPCR 2025

Gain expertise in managing TAVI complications including strategic retrieval of embolized valves, handling unexpected additional valve usage, managing left ventricle suicide phenomenon, and integrating coronary intervention tools during structural heart procedures, supported by instructive case series.

Managing TAVI complications

PCI in cardiogenic shock without left ventricular support

20 May 2025 – From EuroPCR 2025

Explore PCI strategies in cardiogenic shock without left ventricular support through challenging cases including STEMI with single patent vessels, balancing procedural and resource considerations, spontaneous coronary dissections with arrhythmia, and use of crush techniques to rescue critically ill patients.

PCI in cardiogenic shock without left ventricular support

A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients

22 May 2025 – From EuroPCR 2025

This session examines evolving catheterisation lab workflows, highlighting how integrated imaging, physiology, and procedural strategies are reshaping PCI practices. Speakers emphasize the importance of advanced pre-procedural planning using modalities such as intravascular ultrasound (IVUS) to optimise stent deployment, and cardiac computed tomography angiography (CCTA) to improve diagnosis...

A mindset shift in the cathlab: leveraging contemporary technologies for planning and guiding PCI in complex patients

A simple low profile solution to the pulmonary embolism problem: EKOS

21 May 2025 – From EuroPCR 2025

Discover a streamlined approach to pulmonary embolism treatment in this EuroPCR 2025 session. Learn how ultrasound-assisted thrombolysis improves right ventricular function and pulmonary perfusion while enabling timely reperfusion with low-dose thrombolytic therapy delivered directly to the clot. Explore the latest data from the HI-PEITHO randomised trial...

A simple low profile solution to the pulmonary embolism problem: EKOS

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

21 May 2025 – From EuroPCR 2025

Find out more about an innovative transcatheter strategy for managing both primary and secondary mitral regurgitation in this EuroPCR 2025 session. Experts introduce the concept of active posterior leaflet replacement and present the Polares MRace device—a novel solution designed to address the limitations of current therapies....

Active posterior leaflet replacement - A novel transcatheter approach for the treatment of primary and secondary mitral regurgitation

Advanced imaging in structural heart disease interventions

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session brings together expert insights on the evolving role of 3D intracardiac echocardiography (ICE) in procedures like LAA closure, Mitral TEER, and Tricuspid TEER—highlighting how this advanced modality is reshaping procedural guidance.

You'll also discover how AI-enabled device detection technology is being integrated into...

Advanced imaging in structural heart disease interventions

Advancing renal denervation in China: from guidelines to practice

20 May 2025 – From EuroPCR 2025

Discover how renal denervation (RDN) is rapidly evolving in China to meet the needs of patients with uncontrolled hypertension. This EuroPCR 2025 session highlights recent guideline endorsements and approvals, patient selection based on drug resistance and cardiovascular risk, and the critical role of diagnostic screening. Gain...

Advancing renal denervation in China: from guidelines to practice

Advancing the standard of care in PCI with Bioadaptor: from simple to complex

21 May 2025 – From EuroPCR 2025

This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...

Advancing the standard of care in PCI with Bioadaptor: from simple to complex

Align for the future with the Myval Octapro transcatheter heart valve series

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a practical and evidence-based update on the Myval Octapro THV. Learn step-by-step techniques for valve-in-valve TAVI using the OctaAlign approach, and understand how intermediate sizes and precise deployment contribute to optimised hemodynamics and long-term durability.

Clinical insights are backed by key data...

Align for the future with the Myval Octapro transcatheter heart valve series

Broadening OPTIONs for LAA closure: innovations and outcomes

20 May 2025 – From EuroPCR 2025

Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...

Broadening OPTIONs for LAA closure: innovations and outcomes

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a comprehensive update on cardiogenic shock and high-risk PCI, featuring expert analysis of the DanGer-SHOCK and ECLS-SHOCK trials, new insights one year after DanGer-SHOCK, and practical considerations for managing PCI in patients with severely reduced LVEF. Expect to gain a deeper...

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

Challenges and solutions in an expanding TAVI world

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session addresses key challenges and emerging solutions in today’s rapidly evolving TAVI landscape. It presents the latest evidence on valve replacement in low-risk patients with aortic stenosis, alongside strategies for navigating the complexities of lifetime management in TAVI candidates. The programme features a...

Challenges and solutions in an expanding TAVI world

China experience in TAVI evolution

22 May 2025 – From EuroPCR 2025

This session highlights key innovations and recent research from China in the field of transcatheter aortic valve implantation (TAVI). Leading cardiovascular specialist present new data on pacing strategies, comparing left bundle branch area pacing with traditional right ventricular pacing in TAVI patients. They also explore the use...

China experience in TAVI evolution

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

21 May 2025 – From EuroPCR 2025

Cerebral embolic protection (CEP) remains a key consideration in modern TAVI procedures, as stroke continues to be one of the most serious complications. This EuroPCR 2025 session takes a close look at the latest data on CEP use in clinical practice, weighing where it fits best...

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes

20 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 session on complex calcified coronary lesions, follow a step-by-step analysis of a recorded case structured in three key phases: lesion assessment with OCT, PCI using orbital atherectomy, and post-PCI optimisation with follow-up OCT imaging. Gain valuable insights into managing severely calcified lesions,...

Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes

Enhancing clipping solutions for durable long-term patient outcomes

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...

Enhancing clipping solutions for durable long-term patient outcomes

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

20 May 2025 – From EuroPCR 2025

Explore how bifurcation treatment is evolving with the integration of drug-coated balloons, angio-based FFR, and advanced side branch optimisation. This EuroPCR 2025 session highlights why DCB is gaining traction for bifurcation lesions and introduces the upcoming EBC-DCB trial comparing a stepwise DCB strategy to provisional DES...

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

20 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session on managing calcified coronary stenoses, featuring a recorded live case, two focused lectures, and expert faculty insights. Learn why intravascular ultrasound (IVUS) is essential for assessing lesion severity and morphology, discover how selecting the right calcium modification tools drives procedural success...

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions

21 May 2025 – From EuroPCR 2025

Learn how 4D intracardiac echocardiography (ICE) is reshaping structural heart procedures. This EuroPCR 2025 session takes you through the latest in imaging technology—highlighting the benefits of 4D ICE and AI integration in improving the safety, precision, and efficiency of mitral and tricuspid interventions. From valve repair...

From innovation to integration: the evolution of 4D intracardiac echocardiography in structural heart interventions

From theory to practice: the versatility of drug-coated balloons around the world

20 May 2025 – From EuroPCR 2025

Step into the world of drug-coated balloons (DCBs) with this EuroPCR 2025 session, tracing their journey from pioneering use in Europe to versatile applications worldwide. Discover the latest evidence on the safety and efficacy of both paclitaxel- and sirolimus-coated balloons across diverse lesion types—from straightforward to...

From theory to practice: the versatility of drug-coated balloons around the world
Didn’t find what you were looking for?